Drug Negotiation Suits Reflect Lobbying Failures, HHS Says
By Jeff Overley · August 14, 2023, 10:25 PM EDT
A barrage of legal challenges to landmark legislation empowering Medicare to negotiate drug prices is little more than a failed lobbying campaign "masquerading as constitutional theory," the U.S. Department of Health...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login